It is a travel and hospitality private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 | Mumbai, Maharashtra, India | ActiveNovodex Pharma Private Limited, a active private limited company, was established on 17 February 2012 in Mumbai, Maharashtra, India. Engaging in consumer professional services within the professional, scientific and technical sector, it holds CIN: U74999MH2012PTC227081. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹0.10 M.
Formerly known as Rupalheri Estates Private Limited, Novodex Pharma Private Limited. It upholds a compliant status. Its leadership includes Arjun Singh Dhanoa (Director), Ajay Kumar Mehrotra (Director), Jagdeep Dhanoa (Director). Past directors included Ajay Kumar Mehrotra, Ritu Rattan Bhatnagar, Girish Purshottam Talwar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No 601A, Rising Sun Chs Juhu Rd, Juhu, Mumbai, Maharashtra, 400049.
U21001MH2012PTC227081
227081
17 February 2012
₹3.00 Cr
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Novodex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arjun Singh Dhanoa | Director | 29 May 2015 | Current |
| Ajay Kumar Mehrotra | Director | 31 Aug 2020 | Current |
| Jagdeep Dhanoa | Director | 05 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 28 Aug 2017 | Past |
| Pramod Abcsdd | Director | 26 Nov 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Myspace Interior Designers Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 88.66% decrease. The company also saw a substantial fall in profitability, with a 107.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Novodex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Novodex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novodex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novodex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Novodex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Novodex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Ajay Kumar Mehrotra was appointed as a Director was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Progress on Arjun Singh Dhanoa was appointed as a Director was appointed as a Director on 29 May 2015 & has been associated with this company since 10 years 7 months . was documented.
Progress on Jagdeep Dhanoa was appointed as a Director was appointed as a Director on 05 Nov 2012 & has been associated with this company since 13 years 2 months . was documented.
Novodex Pharma Private Limited was registered on 17 Feb 2012 with Roc Mumbai & aged 13 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Novodex Pharma Private Limited is U21001MH2012PTC227081.
Novodex Pharma Private Limited is headquartered at Flat No 601A, Rising Sun Chs Juhu Rd, Juhu, Mumbai, Maharashtra, 400049.
Novodex Pharma Private Limited was incorporated on 17 February 2012.
The current directors of Novodex Pharma Private Limited are
The primary industry of Novodex Pharma Private Limited is Professional, Scientific And Technical.
Novodex Pharma Private Limited is unlisted.
The authorized capital of Novodex Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Novodex Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX